Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Lazaro Gamio/Axios

For 5 years, Elon Musk has been warning about apocalyptic runaway AI, calling it more dangerous than nukes. To stave off his feared future, in 2016 he launched Neuralink, a company to create cyborgs with the express mission of getting ahead of superhuman intelligence.

What's happening: Now, Musk says he has charted the long path to merging man and machine. In an elaborate presentation Tuesday night, he said his company has installed brain–computer links in rats and monkeys and aims to put them inside human skulls next year.

The big picture: Around the world, top research labs are building brain–computer interfaces (BCIs), devices that can both read brain activity directly from neurons and write information straight into the brain.

  • At this early stage, BCIs are being used to treat conditions and injuries related to the brain or nervous system, including Parkinson's disease or paralysis, allowing people to control, and even feel, prosthetic limbs with their minds.
  • In the far future, researchers want to implant interfaces into healthy people. Among their ideas is to use the implants for communication, or a super-efficient connection to an electronic device.

But for Musk, medical uses are a stepping stone to an existential imperative.

  • Last year, he told Axios on HBO that Neuralink's ultimate goal is to "achieve a long-term symbiosis with artificial intelligence."
  • BCI, he says, is the best defense against an alarming future in which AI suddenly surpasses human intelligence and leaves our species behind — or totally imperiled.

Key quote: "This has a very good purpose, which is to cure important diseases — and ultimately to secure humanity's future as a civilization relative to AI," Musk said Tuesday night at the California Academy of Sciences in San Francisco.

Many AI researchers, who still struggle to get computers and robots to complete some basic tasks, disagree with Musk's techno-doomsaying. But Musk has called them "fools."

How it works: Neuralink's system consists of hundreds of electrodes implanted deep inside the brain, connected by tiny wires to a hub that communicates wirelessly with a device behind the wearer's ear. There's also a robotic "sewing machine" that plunges the electrodes into patients' brains.

  • A version of the device has been tested on rats, according to an unreviewed white paper Neuralink circulated after Tuesday's event.
  • And in response to a question on stage, Musk casually dropped that it's also been installed on a monkey, which used it to control a computer. The next step is human testing, which Neuralink hopes to get underway next year.

Reality check: Getting surgical implants into healthy humans is a long shot in the near future, says Kenneth Shepard, a BCI researcher at Columbia University.

  • For the Food and Drug Administration to approve an implant, the upsides have to far outweigh the risks. "And anything that requires surgical implantation comes with a lot of risk," says Shepard.
  • Much more likely to be approved are medical applications that address sensory or motor problems like blindness or paralysis — a significant benefit to outweigh the risks of poking stuff into brains.
  • And those are still out of reach of the best scientists, who are developing devices and software to reliably decode brain activity and send signals back into the mind.

Asked Tuesday how he plans to construct a viable business, Musk said simply that the economics of curing brain diseases and injuries "will easily pay for itself."

  • In the long run, Musk joked, "I think it's safe to say you could repay the loan with superhuman intelligence."

Go deeper: A device to translate brain activity into speech

Go deeper

Sarah Palin tests positive for COVID, delaying defamation trial

Sarah Palin. Photo: Matthew Staver/Bloomberg via Getty Images

Former Alaska Gov. Sarah Palin (R) tested positive for COVID-19 on Monday, delaying the start of her defamation trial against the New York Times.

Why it matters: The trial will be closely watched, as it's a rare instance of a major media company defending its editorial practices before an American jury.

S&P 500 slides into correction territory

Data: FactSet; Chart: Axios Visuals

Stocks suffered their worst drop of the year, pushing the S&P 500 on track to fall into a "correction."

Driving the news: The benchmark S&P 500 dropped for its fifth straight day, with losses nearing 3% in early trading.

Updated 2 hours ago - Politics & Policy

Omicron dashboard

Illustration: Aïda Amer/Axios

  1. Health: Fauci: "Confident" Omicron cases will peak in February — FDA OKs antiviral drug remdesivir for non-hospitalized patients — Walensky: CDC language "pivoting" on "fully vaccinated."
  2. Vaccines: The shifting definition of fully vaccinated — Annual vaccine preferable to boosters, says Pfizer CEO — Team USA 100% vaccinated ahead of Beijing Olympics.
  3. Politics: Virginia school boards sue Gov. Youngkin for lifting mask mandate — Gonzaga University revokes NBA great John Stockton's tickets over mask stance — Arizona governor sues Biden administration over funds tied to mandates.
  4. World: Beijing Olympic Committee lowers testing threshold ahead of Games — Beijing officials urge "emergency mode" before Winter Olympics — Austria approves vaccine mandate for adults.
  5. Variant tracker